NovaBay Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Revenue	14.73	14.4	10.2	9.93	6.6	12.51	18.23	11.9	4.38	1.05	Upgrade
Revenue Growth (YoY)	2.24%	41.16%	2.72%	50.54%	-47.24%	-31.39%	53.23%	171.56%	315.65%	-69.69%	Upgrade
Cost of Revenue	6.83	6.62	3.69	3.97	1.74	1.5	2.78	2.46	1.26	0.49	Upgrade
Gross Profit	7.9	7.78	6.52	5.96	4.86	11.01	15.45	9.43	3.12	0.57	Upgrade
Selling, General & Admin	12.83	15.29	15.33	12.11	14.08	18.62	22.35	19.04	18.53	7.99	Upgrade
Research & Development	0.07	0.17	0.04	0.29	0.18	0.26	0.41	1.37	5.73	9.48	Upgrade
Other Operating Expenses	2.59	6.74	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	15.49	22.2	15.38	12.39	14.26	18.88	22.76	20.42	24.26	17.47	Upgrade
Operating Income	-7.6	-14.42	-8.86	-6.43	-9.4	-7.87	-7.31	-10.98	-21.14	-16.9	Upgrade
Other Expense / Income	2.04	-3.81	-3.04	4.61	0.25	-1.33	0.09	2.17	-2.17	-1.71	Upgrade
Pretax Income	-9.64	-10.61	-5.82	-11.03	-9.65	-6.54	-7.4	-13.15	-18.97	-15.19	Upgrade
Income Tax	0	0	0	0.01	0.01	0	0	0	0	0	Upgrade
Net Income	-9.64	-10.61	-5.82	-11.04	-9.66	-6.55	-7.4	-13.15	-18.97	-15.19	Upgrade
Preferred Dividends	7.06	5.66	0.74	0	0.83	0	0	0	0	0	Upgrade
Net Income Common	-16.7	-16.27	-6.56	-11.04	-10.49	-6.55	-7.4	-13.15	-18.97	-15.19	Upgrade
Shares Outstanding (Basic)	4	2	1	1	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	4	2	1	1	1	0	0	0	0	0	Upgrade
Shares Change	161.80%	29.11%	24.43%	62.08%	26.87%	11.32%	62.88%	237.93%	40.25%	29.99%	Upgrade
EPS (Basic)	-3.96	-10.10	-5.26	-10.85	-16.80	-13.65	-16.80	-49.00	-238.70	-267.75	Upgrade
EPS (Diluted)	-3.96	-10.10	-5.26	-10.85	-16.80	-16.10	-16.80	-49.00	-238.70	-267.75	Upgrade
Free Cash Flow	-4.15	-6.77	-9.24	-4.75	-7.95	-5.61	-6.51	-11.82	-18.65	-15	Upgrade
Free Cash Flow Per Share	-0.98	-4.20	-7.41	-4.74	-12.85	-11.61	-14.88	-43.98	-234.40	-264.40	Upgrade
Gross Margin	53.61%	54.02%	63.85%	60.04%	73.66%	87.98%	84.73%	79.29%	71.22%	53.89%	Upgrade
Operating Margin	-51.58%	-100.09%	-86.85%	-64.69%	-142.45%	-62.93%	-40.10%	-92.31%	-482.47%	-1603.80%	Upgrade
Profit Margin	-113.38%	-112.92%	-64.28%	-111.12%	-158.92%	-52.33%	-40.61%	-110.54%	-433.07%	-1441.56%	Upgrade
Free Cash Flow Margin	-28.18%	-46.97%	-90.59%	-47.79%	-120.44%	-44.87%	-35.73%	-99.36%	-425.59%	-1422.68%	Upgrade
EBITDA	-9.44	-10.13	-5.71	-10.98	-9.59	-6.28	-7.31	-13.04	-18.81	-14.96	Upgrade
EBITDA Margin	-64.08%	-70.29%	-55.91%	-110.56%	-145.28%	-50.17%	-40.07%	-109.57%	-429.29%	-1419.35%	Upgrade
Depreciation & Amortization	0.2	0.48	0.12	0.05	0.07	0.27	0.1	0.11	0.16	0.23	Upgrade
EBIT	-9.64	-10.61	-5.82	-11.03	-9.65	-6.54	-7.4	-13.15	-18.97	-15.19	Upgrade
EBIT Margin	-65.46%	-73.65%	-57.08%	-111.07%	-146.26%	-52.29%	-40.59%	-110.52%	-433.03%	-1441.37%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).